+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Emerging Non-Opioid Pharmaceuticals for Pain Management

  • Report
  • 51 Pages
  • May 2020
  • Region: Global
  • Frost & Sullivan
  • ID: 5090355

Emerging Narcotic-Free Therapies

The research provides technological advances and insights across non-opioid pharmaceuticals for the management of pain. Key application areas explored in the research include neuropathic pain, post-surgical pain, cancer pain, chronic pain, and migraine.

The research encompasses technological advances across Nav1.7 inhibitors, Calcitonin Gene-related peptide inhibitors, Platelet-rich plasma therapy, Ditans, Hydrogel therapy, and stem cell therapy among several others. The research also provides competitive intelligence across emerging innovators in this space, while providing insights across the patent landscape for non-narcotic pain therapy.

Table of Contents

1. Executive Summary
1.1 Key Findings
1.2 Analysis Framework: The Publisher's Core Value
1.3 Research Methodology

2. Technology Landscape and Trends
2.1 Global Non-opioid Market
2.2 NSAIDs Continue to be Important for Pain Treatment
2.3 Types of Non-opioid Pharmaceuticals
2.4 Categories of Non-opioids in Development for Pain Management
2.4.1 Recently Approved Monoclonal Antibodies for Pain Management
2.5 Emerging Non-opioid Analgesics
2.6 Advanced Academic Researches in Pain Therapy

3. Innovation Radar
3.1 Innovation Radar of Emerging Technologies
3.2 Summary of the Scoring Methodology
3.2.1 QBioMed
3.2.2 Centrexion Therapeutics
3.2.3 Concentric Analgesics
3.2.4 Xenon Pharmaceuticals
3.2.5 KinetaBio
3.2.6 Navega Therapeutics
3.2.7 Tetra Biopharma
3.2.8 Vapogenix

4. Growth Opportunities
4.1 Pain Therapy Innovations Roadmap
4.2 Growth Opportunity 1: R&D Investment
4.3 Growth Opportunity 2: Technology Convergence
4.4 Conclusion

5. Patent Analysis
5.1 IP Overview in Non-opioid Pharmaceuticals
5.2 Leading Pharmaceutical Patent Holders
5.3 Patent Scenario
5.3Patent Scenario

6. Appendix
6.1 List of Non-opioids in the Market
6.2 Key Industry Contacts
6.3 Legal Disclaimer

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Centrexion Therapeutics
  • Concentric Analgesics
  • KinetaBio
  • Navega Therapeutics
  • QBioMed
  • Tetra Biopharma
  • Vapogenix
  • Xenon Pharmaceuticals